Ceftazidime: Difference between revisions
No edit summary |
No edit summary |
||
| Line 18: | Line 18: | ||
'''| [[Ceftazidime indications and usage|Indications and Usage]]''' | '''| [[Ceftazidime indications and usage|Indications and Usage]]''' | ||
'''| [[Ceftazidime contraindications|Contraindications]]''' | '''| [[Ceftazidime contraindications|Contraindications]]''' | ||
'''| [[Ceftazidime warnings|Warnings | '''| [[Ceftazidime warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[Ceftazidime adverse reactions|Adverse Reactions]]''' | '''| [[Ceftazidime adverse reactions|Adverse Reactions]]''' | ||
'''| [[Ceftazidime overdosage|Overdosage]]''' | '''| [[Ceftazidime overdosage|Overdosage]]''' | ||
'''| [[Ceftazidime dosage and administration|Dosage and Administration]]''' | '''| [[Ceftazidime dosage and administration|Dosage and Administration]]''' | ||
'''| [[Ceftazidime compatibility | '''| [[Ceftazidime compatibility and stability|Compatibility and Stability]]''' | ||
'''| [[Ceftazidime directions for use|Directions For Use]]''' | '''| [[Ceftazidime directions for use|Directions For Use]]''' | ||
'''| [[Ceftazidime how supplied|How Supplied]]''' | '''| [[Ceftazidime how supplied|How Supplied]]''' | ||
Revision as of 20:01, 30 December 2013
| Ceftazidime |
|---|
| FORATZ®,TAZICEF®,CEFTAZIDIME® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Microbiology |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Overdosage |
| Dosage and Administration |
| Compatibility and stability |
| Directions for use |
| How Supplied |
| Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Ceftazidime (INN) (IPA: Template:IPA) is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram-positive and Gram-negativebacteria. Unlike most third-generation agents, it is active against Pseudomonas aeruginosa, however it has weaker activity against Gram-positive microorganisms and is not used for such infections.
Category
Cephalosporin, Third-Generation
US Brand Names
FORTAZ®, TAZICEF®, CEFTAZIDIME®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Dosage and Administration | Compatibility and Stability | Directions For Use | How Supplied | Labels and Packages
Mechanism of action
References
http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050578s053,050634s020lbl.pdf